Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Cidara Therapeutics (CDTX) Preferred Dividend Payments: 2018-2020

Historic Preferred Dividend Payments for Cidara Therapeutics (CDTX) over the last 2 years, with Dec 2020 value amounting to $2.8 million.

  • Cidara Therapeutics' Preferred Dividend Payments was N/A to $636,000 in Q1 2023 from the same period last year, while for Mar 2023 it was $8.4 million, marking a year-over-year change of. This contributed to the annual value of $2.8 million for FY2020, which is N/A change from last year.
  • Latest data reveals that Cidara Therapeutics reported Preferred Dividend Payments of $2.8 million as of FY2020, which was down 73.26% from $10.3 million recorded in FY2018.
  • Cidara Therapeutics' Preferred Dividend Payments' 5-year high stood at $10.3 million during FY2018, with a 5-year trough of $2.8 million in FY2020.
  • Moreover, its 2-year median value for Preferred Dividend Payments was $6.5 million (2018), whereas its average is $6.5 million.